SC 13G
SC 13G Filing
- Company
- ELITE PHARMACEUTICALS INC /NV/
- Filed
- July 26, 2001
- Accession Number
- 0001144204-01-500029
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →